Can fenbendazole-medicated molasses blocks control Toxocara vitulorum in smallholder cattle and buffalo calves in developing countries? Studies from upland Lao PDR

Title
Can fenbendazole-medicated molasses blocks control Toxocara vitulorum in smallholder cattle and buffalo calves in developing countries? Studies from upland Lao PDR
Publication Date
2020
Author(s)
Olmo, L
( author )
OrcID: https://orcid.org/0000-0001-8175-8216
Email: lolmo@une.edu.au
UNE Id une-id:lolmo
Nampanya, S
Nemanic, T S
Selwood, N
Khounsy, S
Young, J R
Thomson, P C
Bush, R D
Windsor, P A
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
CSIRO Publishing
Place of publication
Australia
DOI
10.1071/an19248
UNE publication id
une:1959.11/60177
Abstract

Context. Anthelmintic treatments are not widely adopted by smallholder farmers in Laos (Lao People’s Democratic Republic) to treat bovid Toxocara vitulorum, resulting in high calf morbidity and mortality.

Aims. Field trials were conducted to provide baseline efficacy data on an alternative, easy-to-use treatment by provision of fenbendazole-medicated molasses blocks (FMB) in situ.

Methods. Participating villages were randomly allocated to the following treatments: (1) conventional orally administered pyrantel, (2) access to FMB, (3) access to non-medicated molasses blocks (MB), and (4) no blocks (control). Faecal eggs per gram (EPG) and weight were monitored in cattle (n = 171) and buffalo calves (n = 44) under field conditions for 48–56 days.

Key results. In 2016, the MB treatment was associated with the fastest reduction in predicted average EPG at 2% per day, while FMB and pyrantel had an equivalent reduction of 1% per day, relative to the control (P = 0.062). Predicted average weight also differed significantly among treatments, with pyrantel and MB having the greatest average daily gain at 230 g and FMB at 200 g, which was higher than for control calves at 170 g (P = 0.002). In buffalo calves, treatment was not significantly associated with EPG or weight. The 2018 trial corroborated that FMB and MB treatments were associated with increased EPG reductions in cattle at 3% per day, relative to control calves (P = 0.007). Again, the MB treatment had the greatest predicted average daily gain at 200 g, compared with FMB calves at 160 g and control calves at 150 g (P = 0.005).

Conclusions. The field trials provided baseline evidence that FMB and MB have potential applications in reducing environmental contamination of T. vitulorum eggs and may improve calf growth in low-input systems. However, further testing ex situ is required to control for variability in calf weight and T. vitulorum burdens, so as to optimise anthelmintic doses, assess the addition of urea to the block formula and assess product marketability.

Implications. If successful, medicated nutrient blocks may be a simple method to reduce calf mortality and morbidity, enhancing the reproductive efficiency of large ruminant production in smallholder farms in developing countries.

Link
Citation
Animal Production Science, 60(17), p. 2031-2043
ISSN
1836-5787
1836-0939
Start page
2031
End page
2043
Rights
Attribution 4.0 International

Files:

NameSizeformatDescriptionLink
openpublished/CanFenbendazoleMedicated2020JournalArticle.pdf 354.249 KB application/pdf Published Version View document